Blue Bell Private Wealth Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$8.23K 729
2025
Q4
$8.23K Hold
200
﹤0.01% 578
2025
Q3
$7.45K Buy
+200
New +$7.27K ﹤0.01% 568
2021
Q1
Sell
-1,455
Closed -$40K 173
2020
Q4
$40K Sell
1,455
-1,056
-42% -$47.9K 0.01% 106
2020
Q3
$60K Sell
2,511
-476
-16% -$20.4K 0.02% 102
2020
Q2
$60K Buy
+2,987
New +$121K 0.03% 91
2014
Q1
Sell
-700
Closed -$25K 389
2013
Q4
$25K Buy
+700
New +$23.5K 0.02% 277

Other funds holding BME

Blue Bell Private Wealth Management's BME Position: Q1 2026 in Review

Blue Bell Private Wealth Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 200 shares — an estimated $8.23K sold.

Blue Bell Private Wealth Management first reported a position in BME in Q4 2013 and held it in 6 quarters. The position peaked at $60K in Q3 2020. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Blue Bell Private Wealth Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 200 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $8.23K.
  • Blue Bell Private Wealth Management first reported a position in BlackRock Health Sciences Trust in Q4 2013 and held it in 6 quarters.
  • Blue Bell Private Wealth Management's BlackRock Health Sciences Trust position peaked at $60K in Q3 2020.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.